AW
BMRN icon

Avion Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Avion Wealth’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Buy
75
+57
+317% +$3.12K ﹤0.01% 834
2026
Q1 		$1K Buy
18
+1
+6% +$58 ﹤0.01% 979
2025
Q4 		$1K Sell
17
-33
-66% -$1.8K ﹤0.01% 980
2025
Q3 		$2K Buy
50
+14
+39% +$801 ﹤0.01% 829
2025
Q2 		$1K Buy
36
+10
+38% +$589 ﹤0.01% 917
2025
Q1 		$1K Hold
26
– – ﹤0.01% 817
2024
Q4 		$1K Sell
26
-15
-37% -$1K ﹤0.01% 814
2024
Q3 		$2K Buy
41
+28
+215% +$2.34K ﹤0.01% 657
2024
Q2 		$1K Sell
13
-5
-28% -$416 ﹤0.01% 689
2024
Q1 		$2K Sell
18
-5
-22% -$448 ﹤0.01% 642
2023
Q4 		$2K Buy
23
+17
+283% +$1.5K ﹤0.01% 536
2023
Q3 		$0 Sell
6
-4
-40% -$356 ﹤0.01% 826
2023
Q2 		$0 Buy
+10
New +$941 ﹤0.01% 729

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Avion Wealth's BMRN Position: Q2 2026 in Review

Avion Wealth increased its BioMarin Pharmaceuticals (BMRN) stake by 317% in Q2 2026, buying an estimated $3.12K and bringing the position to 75 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Avion Wealth first reported a position in BMRN in Q2 2023 and has held it in 13 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Avion Wealth held 75 shares of BioMarin Pharmaceuticals worth $4K as of Q2 2026.
  • Avion Wealth bought 57 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $3.12K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #834 holding.
  • Avion Wealth first reported a position in BioMarin Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.